At3g13403 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
At3g13403 antibody; MRP15 antibody; Defensin-like protein 302 antibody
Target Names
At3g13403
Uniprot No.

Q&A

What is the At3g13403 gene and why is antibody development important for its study?

At3g13403 is an Arabidopsis thaliana gene locus that encodes a specific protein involved in plant cellular processes. Developing antibodies against this protein is crucial for investigating its expression patterns, localization, protein-protein interactions, and functional roles within plant cells. Similar to histone antibodies that have been successfully developed for plant research, At3g13403 antibodies enable researchers to track this specific protein through various experimental approaches . Antibodies serve as essential tools for visualization, quantification, and isolation of target proteins in complex biological systems.

What types of antibodies can be developed for At3g13403 protein detection?

Researchers can develop both polyclonal and monoclonal antibodies for At3g13403 protein detection. Polyclonal antibodies, similar to those developed for histones in plant research, are typically raised in rabbits using synthetic peptides derived from the protein sequence conjugated to carrier proteins like KLH (Keyhole Limpet Hemocyanin) . These antibodies recognize multiple epitopes on the target protein, providing robust detection across various applications. Monoclonal antibodies, while more specific to single epitopes, require more sophisticated hybridoma technology but offer higher specificity and reduced batch-to-batch variation for long-term studies.

What are the recommended applications for At3g13403 antibodies in plant research?

At3g13403 antibodies can be utilized across multiple research applications including:

  • Western blotting (WB) for protein expression analysis

  • Immunofluorescence (IF) for cellular and subcellular localization

  • Chromatin Immunoprecipitation (ChIP) if the protein has DNA-binding properties

  • Co-immunoprecipitation (Co-IP) for protein-protein interaction studies

  • Enzyme-Linked Immunosorbent Assay (ELISA) for quantitative detection

Based on similar antibody applications, recommended dilutions might range from 1:400 for immunofluorescence to 1:5000 for Western blotting, though optimization for each specific antibody is necessary .

How should researchers optimize sample preparation for At3g13403 antibody detection in plant tissues?

Effective sample preparation for At3g13403 antibody detection requires tissue-specific optimization. For protein extraction, researchers should first determine if their target is nuclear, cytoplasmic, or membrane-associated to select appropriate extraction buffers. For nuclei isolation, researchers should perform gentle tissue homogenization in buffer containing nuclear stabilizers followed by filtration and centrifugation steps.

For microscopy applications such as immunofluorescence, fixation parameters must be optimized. Based on successful approaches with other plant proteins, researchers should consider:

  • Fixation with 4% paraformaldehyde for 30-90 minutes (duration varies by species)

  • Membrane permeabilization with 0.5% Triton X-100 for approximately 10 minutes

  • Blocking with 5% fish gelatin to reduce non-specific binding

  • Overnight incubation with primary antibody at 4°C

The protocol should be validated across different tissues and developmental stages to ensure consistent results.

What controls should be included when using At3g13403 antibodies in experimental workflows?

Proper experimental controls are essential for antibody-based research. Researchers should include:

  • Positive controls: Tissues or samples known to express the target protein

  • Negative controls:

    • Primary antibody omission

    • Secondary antibody only

    • Pre-immune serum (for polyclonal antibodies)

    • Samples from knockout lines lacking At3g13403 expression

  • Loading controls: For Western blots, include constitutively expressed proteins (actin, tubulin)

  • Peptide competition assays: Pre-incubating antibody with the immunizing peptide to confirm specificity

  • Cross-reactivity tests: Testing antibody against related proteins to confirm specificity

For ChIP experiments with At3g13403 antibodies, input chromatin normalization is critical for quantitative analysis, similar to approaches used for histone antibodies .

How can researchers validate the specificity of At3g13403 antibodies?

Antibody specificity validation is crucial for reliable research outcomes. A comprehensive validation strategy should include:

  • Western blot analysis: Confirm single band at expected molecular weight (unless multiple isoforms exist)

  • Mass spectrometry: Identify proteins in immunoprecipitated material

  • Genetic validation: Test antibody in knockout/knockdown lines

  • Recombinant protein testing: Compare detection of recombinant vs. native protein

  • Cross-species reactivity: Test antibody across related species if conservation is expected

For targeted validation, researchers can perform epitope mapping to identify the specific amino acid sequences recognized by the antibody. This information helps predict potential cross-reactivity with related proteins and informs experimental design decisions.

How can deep learning approaches improve At3g13403 antibody development and optimization?

Deep learning approaches offer powerful tools for antibody optimization. Similar to methods used for SARS-CoV-2 antibodies, researchers can employ geometric neural network models to predict the effects of amino acid substitutions on antibody-antigen binding affinity . This computational approach allows researchers to:

  • Analyze the complementarity-determining regions (CDRs) of antibodies targeting At3g13403

  • Predict mutations that would enhance binding affinity and specificity

  • Simulate antibody-antigen complex structures to estimate free energy changes (ΔΔG)

  • Perform multi-objective optimization to develop antibodies recognizing multiple protein variants

The iterative process involves computational prediction followed by experimental validation, leading to progressively improved antibodies. For example, studies with SARS-CoV-2 antibodies demonstrated 10- to 600-fold improvements in binding affinity through such approaches .

What are the challenges in detecting post-translational modifications of At3g13403 using antibodies?

Detecting post-translational modifications (PTMs) of At3g13403 presents specific challenges:

  • Specificity requirements: Antibodies must distinguish between modified and unmodified forms of the same protein

  • Epitope accessibility: Some PTMs may alter protein folding, affecting antibody recognition

  • Modification stability: Some PTMs are labile and may be lost during sample processing

  • Modification stoichiometry: Modified forms may represent only a small fraction of total protein

To address these challenges, researchers should:

  • Develop modification-specific antibodies using modified peptides as immunogens

  • Employ enrichment strategies before detection (e.g., phospho-protein enrichment)

  • Use targeted mass spectrometry to confirm antibody specificity for modified epitopes

  • Include appropriate positive controls (e.g., samples treated to enhance the modification)

Validation should include multiple techniques to confirm that the antibody specifically recognizes the modified form of At3g13403.

How can ChIP-seq be optimized for At3g13403 antibodies in plant chromatin studies?

For chromatin immunoprecipitation sequencing (ChIP-seq) with At3g13403 antibodies, researchers should consider the following optimization strategies:

  • Chromatin preparation optimization:

    • Test different crosslinking conditions (1-3% formaldehyde for 5-20 minutes)

    • Optimize sonication parameters to achieve 200-500 bp fragments

    • Evaluate chromatin quality by gel electrophoresis

  • Immunoprecipitation optimization:

    • Determine optimal antibody amount (typically 2.5 μg per 100 μg chromatin)

    • Test different incubation conditions (4°C overnight with rotation)

    • Compare different washing stringencies to reduce background

  • Controls and normalization:

    • Include input chromatin controls

    • Use non-immune IgG for negative controls

    • Consider spike-in normalization with exogenous chromatin

  • Data analysis considerations:

    • Use appropriate peak-calling algorithms

    • Perform replicate concordance analysis

    • Validate key findings with ChIP-qPCR at selected loci

The specificity of the antibody is particularly critical for ChIP-seq applications, as non-specific binding can lead to false positive peaks in the data.

How can researchers address weak or absent signals when using At3g13403 antibodies?

When encountering weak or absent signals with At3g13403 antibodies, researchers should systematically evaluate:

  • Protein expression levels:

    • Confirm target protein expression in the sample

    • Consider developmental timing or induction conditions

    • Use positive control samples with known expression

  • Antibody quality issues:

    • Test antibody functionality with dot blot using immunizing peptide

    • Evaluate different antibody dilutions (wider range than recommended)

    • Check antibody storage conditions and freeze-thaw cycles

  • Protocol optimization:

    • Increase protein amount loaded for Western blots

    • Extend primary antibody incubation time or temperature

    • Try different membrane types (PVDF vs. nitrocellulose)

    • Test alternative blocking agents (BSA vs. milk vs. fish gelatin)

    • Optimize antigen retrieval methods for fixed samples

  • Detection system sensitivity:

    • Switch to more sensitive detection methods (chemiluminescence vs. fluorescence)

    • Use signal enhancement systems (biotin-streptavidin amplification)

    • Consider longer exposure times for Western blots

Systematic testing of these variables will help identify and address the specific cause of weak signals.

What strategies can resolve high background when using At3g13403 antibodies in immunofluorescence?

High background in immunofluorescence with At3g13403 antibodies can be addressed through these strategies:

  • Fixation optimization:

    • Test different fixatives (paraformaldehyde vs. methanol)

    • Optimize fixation time and concentration

    • Consider adding permeabilization steps with detergents like Triton X-100 (0.5%)

  • Blocking improvements:

    • Try different blocking agents (BSA, fish gelatin, normal serum)

    • Increase blocking time or concentration

    • Add detergents to blocking solution

  • Antibody conditions:

    • Further dilute primary and secondary antibodies

    • Reduce incubation temperature (4°C instead of room temperature)

    • Pre-absorb antibodies with plant extract from knockout lines

  • Washing optimization:

    • Increase number and duration of washes

    • Add detergents or salt to washing buffers

    • Perform washing steps at different temperatures

  • Tissue-specific considerations:

    • Address autofluorescence with appropriate quenching agents

    • Consider counterstaining with DAPI to better visualize nuclei

    • Use confocal microscopy with appropriate filter settings

Sample preparation quality is particularly important for plant tissues, which may require specialized processing to reduce autofluorescence and improve antibody penetration.

How can researchers use At3g13403 antibodies to study protein-protein interactions in planta?

At3g13403 antibodies can be powerful tools for studying protein-protein interactions through several approaches:

  • Co-immunoprecipitation (Co-IP):

    • Use At3g13403 antibodies to pull down the target protein and associated partners

    • Optimize lysis conditions to preserve interactions (mild detergents, physiological salt)

    • Identify binding partners by mass spectrometry or targeted Western blotting

    • Include appropriate controls (IgG, knockout lines) to identify specific interactions

  • Proximity labeling approaches:

    • Generate fusion proteins with promiscuous biotin ligases (BioID) or peroxidases (APEX)

    • Use At3g13403 antibodies to confirm expression and localization

    • Identify interaction neighbors through streptavidin purification and mass spectrometry

  • Fluorescence microscopy techniques:

    • Perform dual immunofluorescence with At3g13403 antibodies and potential interactors

    • Calculate colocalization coefficients between signals

    • Use proximity ligation assays (PLA) to visualize proteins in close proximity (<40 nm)

  • Chromatin-associated interactions:

    • For nuclear proteins, perform sequential ChIP (ChIP-reChIP) to identify co-occupancy

    • Use At3g13403 antibodies in combination with antibodies against known chromatin factors

These approaches provide complementary data about the protein interaction network of At3g13403, enabling researchers to build comprehensive models of its function.

What considerations are important when using At3g13403 antibodies across different plant species?

When extending At3g13403 antibody use to different plant species, researchers should consider:

  • Sequence conservation analysis:

    • Perform sequence alignment of At3g13403 homologs across target species

    • Focus on conservation at the specific epitope targeted by the antibody

    • Predict potential cross-reactivity based on sequence identity percentages

  • Validation requirements:

    • Test antibody reactivity in each new species before experimental use

    • Perform Western blots to confirm band size and specificity

    • Include positive controls (Arabidopsis samples) alongside new species

    • Consider using recombinant proteins from the target species as standards

  • Protocol adaptations:

    • Adjust extraction buffers for species-specific differences in cell wall composition

    • Modify fixation times for immunofluorescence based on tissue permeability

    • Optimize antibody concentrations for each species

  • Interpretation considerations:

    • Account for potential differences in protein function across species

    • Consider evolutionary distance when interpreting results

    • Be aware of potential paralog detection due to gene duplications

As observed with histone antibodies, cross-reactivity can often be predicted based on sequence conservation, with antibodies developed against Arabidopsis proteins frequently recognizing homologs in related species like Brassica, Solanum, and even monocots like rice and maize .

What future developments can we expect in antibody technology for plant protein research?

The field of plant protein research using antibodies is likely to advance in several directions:

  • Technical improvements in antibody development:

    • Increased use of computational approaches, including deep learning, to optimize antibody binding properties

    • Development of recombinant antibodies with enhanced specificity and reproducibility

    • Creation of nanobodies (single-domain antibodies) for improved tissue penetration

    • Integration of synthetic biology approaches for novel binding properties

  • Enhanced detection methods:

    • Development of multiplexed detection systems to track multiple proteins simultaneously

    • Implementation of super-resolution microscopy techniques for nanoscale localization

    • Adoption of microfluidic and single-cell technologies for higher throughput analysis

    • Integration with cryo-electron microscopy for structural studies

  • Data integration approaches:

    • Combination of antibody-based detection with multi-omics data

    • Development of machine learning tools to analyze complex localization patterns

    • Creation of standardized validation pipelines for antibody characterization

    • Establishment of community resources for sharing validated antibodies and protocols

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.